Arrowhead Pharmaceuticals Inc. (ARWR) Misses Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $87.25 -2.23%
Financial Fact:
NET INCOME (LOSS): -19.42M
Today's EPS Names:
FRMM, PETS, DARE, More
Financial Fact:
NET INCOME (LOSS): -19.42M
Today's EPS Names:
FRMM, PETS, DARE, More
Join SI Premium – FREE
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q3 EPS of ($0.13), $0.01 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $27.4 million versus the consensus estimate of $28.91 million.
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
- Capstone Energy+, Inc. (CEPL) Reports Q2 Loss of $0.03
- Epsilon Energy Ltd. (EPSN) Reports Q2 EPS of $0.23
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
